Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D
S. Timmerman, Anne‐Sophie Van Rompuy, Toon Van Gorp, et al.
Gynecologic Oncology (2020) Vol. 157, Iss. 1, pp. 245-251
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Meta-analysis of the clinicopathologic features of endometrial cancer molecular staging
Xiaoxia Yin, Bing Luo, Yong Li
Frontiers in Oncology (2025) Vol. 14
Open Access | Times Cited: 1
Clinical features of ProMisE groups identify different phenotypes of patients with endometrial cancer
Antonio Raffone, Antonio Travaglino, Olimpia Gabrielli, et al.
Archives of Gynecology and Obstetrics (2021) Vol. 303, Iss. 6, pp. 1393-1400
Open Access | Times Cited: 47
Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review
Luigi Antonio De Vitis, Gabriella Schivardi, Giuseppe Caruso, et al.
International Journal of Gynecological Cancer (2023) Vol. 34, Iss. 2, pp. 229-238
Open Access | Times Cited: 21
Mismatch Repair Deficiency and Microsatellite Instability in Triple-Negative Breast Cancer: A Retrospective Study of 440 Patients
Xinyu Ren, Yu Song, Jing Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 39
Race, Prevalence of POLE and POLD1 Alterations, and Survival Among Patients With Endometrial Cancer
Shuhua Zheng, Eric D. Donnelly, Jonathan Strauss
JAMA Network Open (2024) Vol. 7, Iss. 1, pp. e2351906-e2351906
Open Access | Times Cited: 5
The Role of Immunohistochemistry Markers in Endometrial Cancer with Mismatch Repair Deficiency: A Systematic Review
Amélia Favier, Justine Varinot, Cathérine Uzan, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3783-3783
Open Access | Times Cited: 22
Clinical characteristics and prognostic characterization of endometrial carcinoma: a comparative analysis of molecular typing protocols
Zihui Yang, Xi Yang, Xinyu Liu, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Plasma-based microsatellite instability detection strategy to guide immune checkpoint blockade treatment
Zhenghang Wang, Xiaochen Zhao, Chan Gao, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001297-e001297
Open Access | Times Cited: 30
Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type
Hiroyuki Matsubayashi, Takuma Oishi, Keiko Sasaki, et al.
Human Pathology (2022) Vol. 135, pp. 54-64
Closed Access | Times Cited: 18
Validity of a two-antibody testing algorithm for mismatch repair deficiency testing in cancer; a systematic literature review and meta-analysis
K.T.S. Aiyer, Thom Doeleman, Neil Ryan, et al.
Modern Pathology (2022) Vol. 35, Iss. 12, pp. 1775-1783
Open Access | Times Cited: 17
Molecular profile in endometrial carcinoma: can we predict the lymph node status? A systematic review and meta-analysis
Ana Luzarraga Aznar, Vicente Bebia, Natalia R. Gómez-Hidalgo, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 7, pp. 1768-1778
Closed Access | Times Cited: 3
The association between body mass index and molecular subtypes in endometrial carcinoma
D.J. Smith, Eun Young Kang, Gregg Nelson, et al.
Gynecologic Oncology Reports (2024) Vol. 54, pp. 101447-101447
Open Access | Times Cited: 3
Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods
Richard K. Yang, Hui Chen, Sinchita Roy‐Chowdhuri, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4550-4550
Open Access | Times Cited: 12
Circumcision Complications
Feride Mehmetoğlu
Özgür Yayınları eBooks (2023)
Open Access | Times Cited: 6
Nomograms based on the novel platelet index score predict postoperative prognosis in endometrial cancer
Hao Chen, Qi‐Jun Wu, Yunzheng Zhang, et al.
Gynecologic Oncology (2020) Vol. 158, Iss. 3, pp. 689-697
Closed Access | Times Cited: 15
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early‐stage endometrial cancer: A propensity score–matched analysis
Camilla Nero, Tina Pasciuto, Serena Cappuccio, et al.
Cancer (2022) Vol. 128, Iss. 15, pp. 2898-2907
Open Access | Times Cited: 9
Comprehensive immunomolecular profiling of endometrial carcinoma: A tertiary retrospective study
Jasper Victoor, Sara Vander Borght, Lien Spans, et al.
Gynecologic Oncology (2021) Vol. 162, Iss. 3, pp. 694-701
Closed Access | Times Cited: 11
Low‐density lipoprotein receptor‐related protein 5/6 promotes endometrial cancer progression and cancer cell immune escape
Lifan Shen, Chen Zhang, Genhai Zhu
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 4
Closed Access | Times Cited: 1
Morphomolecular Correlation and Clinicopathologic Analysis in Endometrial Carcinoma
Göksenil Bülbül, Tekincan Çağrı Aktaş, Anıl Aysal Ağalar, et al.
International Journal of Gynecological Pathology (2024) Vol. 43, Iss. 6, pp. 535-556
Closed Access | Times Cited: 1
Abnormal p53 High-Grade Endometrioid Endometrial Cancer: A Systematic Review and Meta-Analysis
João Casanova, Alexandru Babiciu, Gonçalo S. Duarte, et al.
Cancers (2024) Vol. 17, Iss. 1, pp. 38-38
Open Access | Times Cited: 1
Research Progress of DNA Methylation Markers for Endometrial Carcinoma Diagnosis
Haoning Zheng, Changhua Yu, Lu Yang, et al.
Journal of Cancer (2024) Vol. 16, Iss. 3, pp. 812-820
Open Access | Times Cited: 1
Analysis of patients with endometrial carcinoma using the ProMise classifier: a pilot study from India
Alka Dahiya, Abarna Rajadurai, Sherin Daniel, et al.
Archives of Gynecology and Obstetrics (2023) Vol. 309, Iss. 4, pp. 1499-1508
Closed Access | Times Cited: 3
The Advantages of Next-Generation Sequencing Molecular Classification in Endometrial Cancer Diagnosis
Daniela Rivera, Michele Paudice, Giulia Accorsi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 23, pp. 7236-7236
Open Access | Times Cited: 3
Less is more in endometrial cancer (SLN, conservative treatment, radical hysterectomy, molecular classification)
Guillaume Parpex, Chloé Lieng, Martin Koskas
Current Opinion in Oncology (2022) Vol. 34, Iss. 5, pp. 511-517
Closed Access | Times Cited: 4
The Advantages of NGS Molecular Classification in Endometrial Cancer Diagnosis
Daniela Rivera, Michele Paudice, Giulia Accorsi, et al.
(2023)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top